<DOC>
	<DOCNO>NCT01397240</DOCNO>
	<brief_summary>The purpose study research safety efficacy Albis® prevention aspirin-induced gastrointestinal ulcer patient take low-dose aspirin .</brief_summary>
	<brief_title>The Safety Efficacy Albis® : The Prevention Aspirin-induced Gastrointestinal Ulcers Patients</brief_title>
	<detailed_description>The Safety Efficacy Albis® : The Prevention Aspirin-induced Gastrointestinal Ulcers Patients take Low-dose Aspirin , A pilot study Double-Blind , Placebo-Controlled , Randomized , Multicenter , Parallel , Prospective study</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Male female , age 20 80 year Subjects identify least one follow diagnosis ( Angina , Myocardial Infarction ( Old ) , Cerebrovascular Disease , Peripheral Vascular Disease , Diabetes , Hypertension , Hypercholeseterolemia , Obesity ) require take low dose Aspirin ( 100mg/day ) 12 week . Females pregnant , nursing , plan pregnancy study period female childbearing potential Peptic ulcer Reflux oesophagitis hemostatic disorder coagulation disorder Known allergy hypersensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>